Subira Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
- Satisfied Charges ₹ 1.96 Cr
- Revenue Growth 17.60%
- Profit Growth -24.26%
- Ebitda -33.85%
- Net Worth 21.12%
- Total Assets 25.58%
About Subira Pharmaceuticals
Subira Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 October 2013 and has a history of 11 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹1.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vishal Khanna and Kavita Khanna serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233MH2013PTC328984
- Company No.
328984
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Subira Pharmaceuticals Private Limited
Explore comprehensive data for Subira Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Subira Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Khanna  | Director | 08-Oct-2013 | Current |
| Kavita Khanna | Director | 08-Oct-2013 | Current |
Financial Performance of Subira Pharmaceuticals.
Subira Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.6% increase. The company also saw a substantial fall in profitability, with a 24.26% decrease in profit. The company's net worth Soared by an impressive increase of 21.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Subira Pharmaceuticals?
In 2023, Subira Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹2.50 M
Satisfied Charges
₹19.57 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2022 | Hdfc Bank Limited | ₹2.50 M | Open |
| 01 Dec 2020 | Others | ₹1.96 Cr | Satisfied |
How Many Employees Work at Subira Pharmaceuticals?
Unlock and access historical data on people associated with Subira Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Subira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subira Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Subira Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Subira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Subira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100571724 was registered on 04 May 2022.
- Charges
A charge registered on 01 Dec 2020 via Charge ID 100401055 with Others was fully satisfied on 03 Feb 2022.
- Charges
A charge with Others amounted to Rs. 19.57 M with Charge ID 100401055 was registered on 01 Dec 2020.
- Director Appointment
Kavita Khanna was appointed as a Director was appointed as a Director on 08 Oct 2013 & has been associated with this company since 11 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Subira Pharmaceuticals Private Limited?
Subira Pharmaceuticals Private Limited was incorporated on 08 Oct 2013.
What is authorized share capital and paid-up capital of Subira Pharmaceuticals Private Limited?
The authorized share capital of Subira Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Subira Pharmaceuticals Private Limited?
Currently 2 directors are associated with Subira Pharmaceuticals Private Limited.
- Vishal Khanna
- Kavita Khanna
What is the registered address of Subira Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Subira Pharmaceuticals Private Limited is A-408 Fairlink Centre Chs Ltd. Off. Link Road, Andheri West India, Mumbai, Maharashtra, 400053.
What is the corporate identification number (CIN) and company number of Subira Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Subira Pharmaceuticals Private Limited is U24233MH2013PTC328984 and the company number is 328984 as per Ministry of Corporate Affairs (MCA).
What is the official website of Subira Pharmaceuticals Private Limited?
The Official website of Subira Pharmaceuticals Private Limited is https://www.subirapharma.in
What has been the recent revenue trend for Subira Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Subira Pharmaceuticals Private Limited has risen by 17.60%.
What change has been observed in the net worth of Subira Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Subira Pharmaceuticals Private Limited has experienced an upsurge of 21.12%.
What are the total open charges for Subira Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Subira Pharmaceuticals Private Limited amount to ₹ 2.50 M.
When was the last Balance Sheet of Subira Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Subira Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records